TABLE 1 Europe Antibiotics Market, 2016 - 2019, USD Million
TABLE 2 Europe Antibiotics Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antibiotics Market
TABLE 4 Product Launches And Product Expansions– Antibiotics Market
TABLE 5 Approvals– Antibiotics Market
TABLE 6 Acquisition and Mergers– Antibiotics Market
TABLE 7 Europe Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 8 Europe Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 9 Europe Cell Wall Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 10 Europe Cell Wall Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 11 Europe Protein Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 12 Europe Protein Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 13 Europe DNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 14 Europe DNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 15 Europe RNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 16 Europe RNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 17 Europe Others Market by Country, 2016 - 2019, USD Million
TABLE 18 Europe Others Market by Country, 2020 - 2026, USD Million
TABLE 19 Europe Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 20 Europe Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 21 Europe Cephalosporin Market by Country, 2016 - 2019, USD Million
TABLE 22 Europe Cephalosporin Market by Country, 2020 - 2026, USD Million
TABLE 23 Europe Penicillin Market by Country, 2016 - 2019, USD Million
TABLE 24 Europe Penicillin Market by Country, 2020 - 2026, USD Million
TABLE 25 Europe Fluoroquinolone Market by Country, 2016 - 2019, USD Million
TABLE 26 Europe Fluoroquinolone Market by Country, 2020 - 2026, USD Million
TABLE 27 Europe Macrolides Market by Country, 2016 - 2019, USD Million
TABLE 28 Europe Macrolides Market by Country, 2020 - 2026, USD Million
TABLE 29 Europe Carbapenem Market by Country, 2016 - 2019, USD Million
TABLE 30 Europe Carbapenem Market by Country, 2020 - 2026, USD Million
TABLE 31 Europe Aminoglycosides Market by Country, 2016 - 2019, USD Million
TABLE 32 Europe Aminoglycosides Market by Country, 2020 - 2026, USD Million
TABLE 33 Europe Sulfonamides Market by Country, 2016 - 2019, USD Million
TABLE 34 Europe Sulfonamides Market by Country, 2020 - 2026, USD Million
TABLE 35 Europe Others Market by Country, 2016 - 2019, USD Million
TABLE 36 Europe Others Market by Country, 2020 - 2026, USD Million
TABLE 37 Europe Antibiotics Market by Country, 2016 - 2019, USD Million
TABLE 38 Europe Antibiotics Market by Country, 2020 - 2026, USD Million
TABLE 39 Germany Antibiotics Market, 2016 - 2019, USD Million
TABLE 40 Germany Antibiotics Market, 2020 - 2026, USD Million
TABLE 41 Germany Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 42 Germany Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 43 Germany Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 44 Germany Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 45 UK Antibiotics Market, 2016 - 2019, USD Million
TABLE 46 UK Antibiotics Market, 2020 - 2026, USD Million
TABLE 47 UK Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 48 UK Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 49 UK Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 50 UK Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 51 France Antibiotics Market, 2016 - 2019, USD Million
TABLE 52 France Antibiotics Market, 2020 - 2026, USD Million
TABLE 53 France Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 54 France Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 55 France Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 56 France Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 57 Russia Antibiotics Market, 2016 - 2019, USD Million
TABLE 58 Russia Antibiotics Market, 2020 - 2026, USD Million
TABLE 59 Russia Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 60 Russia Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 61 Russia Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 62 Russia Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 63 Spain Antibiotics Market, 2016 - 2019, USD Million
TABLE 64 Spain Antibiotics Market, 2020 - 2026, USD Million
TABLE 65 Spain Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 66 Spain Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 67 Spain Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 68 Spain Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 69 Italy Antibiotics Market, 2016 - 2019, USD Million
TABLE 70 Italy Antibiotics Market, 2020 - 2026, USD Million
TABLE 71 Italy Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 72 Italy Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 73 Italy Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 74 Italy Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 75 Rest of Europe Antibiotics Market, 2016 - 2019, USD Million
TABLE 76 Rest of Europe Antibiotics Market, 2020 - 2026, USD Million
TABLE 77 Rest of Europe Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 78 Rest of Europe Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 79 Rest of Europe Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 80 Rest of Europe Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 81 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 82 Key information –Johnson and Johnson
TABLE 83 key information - Merck & Co., Inc.
TABLE 84 Key Information – Pfizer, Inc.
TABLE 85 Key Information – Bayer AG
TABLE 86 Key Information – Novartis AG
TABLE 87 Key Information – Sanofi S.A.
TABLE 88 Key Information – Abbott Laboratories
TABLE 89 key information – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Eli Lilly and Company
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Jul) Leading Players
FIG 5 Recent strategies and developments: Merck & Co., Inc.
FIG 6 Recent strategies and developments: Pfizer, Inc.
FIG 7 Recent strategies and developments: Sanofi S.A.
Unique Offerings 